Organon Belgium financials
A multi-period view of the public annual-account figures reported for Organon Belgium, with comparable measures and links to available source documents.
Company overviewRegistry number
0741785526
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Organon Belgium
2025 versus 2024
- Operating line
- €78,500,450
- EBITDA
- €3,179,715
- Total assets
- €25,241,241
- Equity
- €14,805,565
+12.3%
+3.9%
+10.2%
+18.7%
EBITDA margin +4.1% · Equity ratio +58.7%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €78,500,450 | €3,179,715 | €25,241,241 | €14,805,565 | - |
| 202431 Dec 2024 | €69,927,566 | €3,061,461 | €22,904,454 | €12,474,304 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.